Browse evidence-based analysis of health-related claims and assertions
Log in to see full claim details, scientific mechanisms, and cited studies.
Even after accounting for whether people had received other vaccines like Tdap or the older shingles vaccine, the link between the new shingles vaccine and lower dementia risk still held up,...
The link between receiving two doses of the shingles vaccine and lower dementia risk remains strong even after more than three years, indicating the benefit doesn’t fade quickly over time.
Older adults who received two doses of the shingles vaccine had a 33% lower rate of developing vascular dementia over nearly three years compared to those who did not receive the vaccine.
Older adults who received two doses of the shingles vaccine had a 28% lower rate of developing Alzheimer’s disease over nearly three years compared to those who did not receive the vaccine.
Among adults aged 65 and older, receiving two doses of the shingles vaccine is associated with a 26% to 33% lower rate of developing dementia over several years compared to those who did not receive...
Over six months of monitoring, no one in the study who received the recombinant zoster vaccine had a life-threatening reaction, autoimmune condition, or died as a result of the vaccine.
People aged 50 and older who received the recombinant zoster vaccine were more likely to experience temporary side effects like soreness, tiredness, or headaches than those who received a placebo,...
The level of protective antibodies generated by the recombinant zoster vaccine in Indian adults over 50 is similar to what has been seen in people from other countries, indicating the vaccine works...
In adults aged 50 and older in India, the recombinant zoster vaccine caused mostly mild or moderate side effects like soreness or fatigue, and no life-threatening reactions, hospitalizations, or...
Two doses of the recombinant zoster vaccine, given two months apart, cause a strong increase in protective antibodies against the virus that causes shingles in people aged 50 and older in India, with...
People with HIV who also have hepatitis C are nearly 50% more likely to have a stroke than those without hepatitis C, even after accounting for high blood pressure, cholesterol, and other health...
People with HIV who take protease inhibitor-based antiretroviral therapy have a 33% higher chance of having a stroke than those on other regimens, even after accounting for high blood pressure,...
High blood pressure is the most powerful predictor of stroke in people with HIV, increasing the risk more than threefold compared to those without hypertension.
In people with HIV, the longer herpes zoster lasts alongside HIV infection—especially beyond six months—the higher the chance of having a stroke, even after accounting for other health conditions.
Among people with HIV, those who develop shingles are about 1.85 times more likely to have a stroke than those who do not, even after accounting for other known stroke risk factors like high blood...
The link between shingles and stroke only appears in people who were prescribed antiviral medication, meaning the shingles diagnosis was verified by a doctor and not just assumed.
Shingles does not raise stroke risk for more than a few months; if someone has a stroke a year or more after shingles, it’s not likely because of the shingles infection.
People who have had shingles in the last three months are nearly three times more likely to have a brain bleed than a blockage in a brain artery, compared to people without recent shingles.
The increased stroke risk linked to shingles only lasts for about three months after the infection; after a year, the risk returns to normal levels.
People who have had shingles in the past 90 days are more likely to have a stroke, especially a type called intracerebral hemorrhage, compared to those who haven't had shingles recently.
Fewer than 1 in 50 older adults who developed shingles had received the shingles vaccine before infection, and fewer than 1 in 17 received both the vaccine and antiviral treatment, indicating that...
After shingles, the risk of stroke is highest in the first two weeks and drops steadily over the next six months, returning to nearly normal levels by six months, showing that the danger is temporary...
The increased stroke risk after shingles is similar for men and women, older and younger seniors, and across racial groups, except that men have a slightly higher risk 1–3 months after infection and...
Getting the shingles vaccine before infection or taking antiviral drugs after infection does not reduce the increased stroke risk that follows shingles in older adults, based on analysis of over...